4//SEC Filing
EYEGATE PHARMACEUTICALS INC 4
Accession 0001144204-16-108387
$KPRXCIK 0001372514operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:10 PM ET
Size
5.1 KB
Accession
0001144204-16-108387
Insider Transaction Report
Form 4
GOLDBERG MORTON
Director
Transactions
- Sale
Common Stock
2016-06-15$3.16/sh−15,000$47,361→ 17,277 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.15 to $3.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeoperating
Related Parties
1- filerCIK 0001372514
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 5:10 PM ET
- Size
- 5.1 KB